GLP-1 Stocks Aren't the Only Way to Benefit From the Weight Loss Drugs Boom
13/10 15:30
By now, nearly everyone has heard of the weight loss drugs targeted at the glucagon-like protein 1 (GLP-1) receptor, like Zepbound and Wegovy by Eli Lilly and Novo Nordisk, respectively. It's no surprise why they're household names; those medicines are bringing in billions of rev...